Clinical Trials and Research1 min read
Not so benign: Life-threatening hematuria from renal papillary necrosis in sickle cell trait
About this article
- Published
- Further reading
- Read More(opens in a new tab)
Highlights
- Sickle cell trait can cause severe, transfusion-dependent hematuria -- not always benign; requires thorough evaluation.
- Consider renal papillary necrosis for recurrent hematuria with negative malignancy workup.
- Management requires a stepwise and multidisciplinary approach.
- Amicar can be a salvage option for refractory hematuria, even in thrombotic-risk patients, if used with close monitoring.